1 week Ago By ABMN Staff
Royal Bank of Canada reissued their outperform rating on shares of Danaher ( NYSE:DHR – Free Report ) in a report issued on Friday, Benzinga reports. The brokerage currently has a $300.00 price objective on the conglomerate’s stock.
Several other equities research analysts have also recently commented on the stock. Robert W. Baird raised their target price on shares of Danaher from $271.
00 to $278.00 and gave the stock an outperform rating in a research report on Wednesday, July 24th. StockNews.
com cut shares of Danaher from a buy rating to a hold rating in a research report on Tuesday, June 25th. Wells Fargo & Company started coverage on shares of Danaher in a research report on Tuesday, August 27th. They issued an equal weight rating and a $280.
00 target price for the company. Bank of America raised their target price on shares of Danaher from $270.00 to $275.
00 and gave the stock a neutral rating in a research report on Wednesday, July 24th. Finally, Jefferies Financial Group started coverage on shares of Danaher in a research report on Monday, June 3rd. They set a buy rating and a $295.
00 price target for the company. Seven research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of Moderate Buy and an average price target of $278.
94. Read Our Latest Report on Danaher Danaher Trading Up 0.6 % Danaher ( NYSE:DHR – Get Free Report ) last announced its quarterly earnings results on Tuesday, July 23rd.
The conglomerate reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.
15. Danaher had a net margin of 16.94% and a return on equity of 11.
06%. The business had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.
59 billion. During the same quarter in the prior year, the company posted $2.05 EPS.
The firm’s revenue for the quarter was down 2.9% compared to the same quarter last year. On average, research analysts anticipate that Danaher will post 7.
59 EPS for the current year. Insider Buying and Selling at Danaher In other news, CFO Matthew Mcgrew sold 16,172 shares of Danaher stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $279.
84, for a total value of $4,525,572.48. Following the completion of the sale, the chief financial officer now directly owns 29,407 shares in the company, valued at $8,229,254.
88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink . In other news, SVP Brian W.
Ellis sold 9,600 shares of Danaher stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.
00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $5,566,486.80.
The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink . Also, CFO Matthew Mcgrew sold 16,172 shares of Danaher stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $279.
84, for a total transaction of $4,525,572.48. Following the completion of the sale, the chief financial officer now owns 29,407 shares of the company’s stock, valued at $8,229,254.
88. The disclosure for this sale can be found here . In the last ninety days, insiders sold 39,659 shares of company stock worth $11,042,433.
11.10% of the stock is owned by corporate insiders. Institutional Trading of Danaher A number of large investors have recently made changes to their positions in the stock.
Cape Investment Advisory Inc. bought a new stake in Danaher during the fourth quarter valued at approximately $25,000. Tsfg LLC grew its position in Danaher by 733.
3% during the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after buying an additional 88 shares during the period. CarsonAllaria Wealth Management Ltd.
bought a new stake in Danaher during the second quarter valued at approximately $25,000. nVerses Capital LLC bought a new stake in Danaher during the second quarter valued at approximately $25,000. Finally, Redmont Wealth Advisors LLC bought a new stake in Danaher during the first quarter valued at approximately $30,000.
79.05% of the stock is currently owned by institutional investors. About Danaher ( Get Free Report ) Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. Featured Stories Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter .
.
